Fortitude Family Office’s Myriad Genetics MYGN Stock Holding History

Fortitude Family Office’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.46K	Buy	+256	New	+$1.16K	﹤0.01%	1610

Other funds holding MYGN

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Impact Capital Partners Greenwood Village, Colorado $367M AUM 28.36% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Fortitude Family Office's MYGN Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Myriad Genetics (MYGN) in Q2 2026: 256 shares worth $1.46K. The stake represents ﹤0.01% of the portfolio and ranks #1610 among its holdings.

22 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

Fortitude Family Office held 256 shares of Myriad Genetics worth $1.46K as of Q2 2026.
Myriad Genetics was a new Fortitude Family Office position in Q2 2026.
Myriad Genetics made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1610 holding.
22 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.